Journal of Virology, July 2005, p. 8189-8200, Vol. 79, No. 13
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.13.8189-8200.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins
Gillis R. Otten,1*
Mary Schaefer,1
Barbara Doe,1
Hong Liu,1
Indresh Srivastava,1
Jan zur Megede,1
Jina Kazzaz,1
Ying Lian,1
Manmohan Singh,1
Mildred Ugozzoli,1
David Montefiori,2
Mark Lewis,3,
David A. Driver,1,
Thomas Dubensky,1,
John M. Polo,1
John Donnelly,1
Derek T. O'Hagan,1
Susan Barnett,1 and
Jeffrey B. Ulmer1
Chiron Corporation, Emeryville, California,1
Duke University Medical Center, Durham, North Carolina,2
Southern Research Institute, Frederick, Maryland3
Received 11 November 2004/
Accepted 17 March 2005
DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for increasing the potency of DNA vaccines in rhesus macaques. These included DNA encoding Sindbis virus RNA replicons (pSINCP), cationic poly(lactide-co-glycolide) (PLG) microparticles for DNA delivery, and recombinant protein boosting. The DNA-based pSINCP replicon vaccines encoding HIV Gag and Env were approximately equal in potency to human cytomegalovirus (CMV) promoter-driven conventional DNA vaccines (pCMV). The PLG microparticle DNA delivery system was particularly effective at enhancing antibody responses induced by both pCMV and pSINCP vaccines and had less effect on T cells. Recombinant Gag and Env protein boosting elicited rapid and strong recall responses, in some cases to levels exceeding those seen after DNA or DNA/PLG priming. Of note, Env protein boosting induced serum-neutralizing antibodies and increased frequencies of gamma interferon-producing CD4 T cells severalfold. Thus, PLG microparticles are an effective means of delivering DNA vaccines in nonhuman primates, as demonstrated for two different types of DNA vaccines encoding two different antigens, and are compatible for use with DNA prime-protein boost regimens.
* Corresponding author. Mailing address: Chiron Corporation, 4560 Horton St., Mail Stop 4.3, Emeryville, CA 94608. Phone: (510) 923-2965. Fax: (510) 923-2586. E-mail: gillis_otten{at}chiron.com.
Present address: BioQual, Rockville, MD 20850.
Present address: BioMedica Inc., San Diego, CA 92121.
Present address: Cerus Corporation, Concord, CA 94520.
Journal of Virology, July 2005, p. 8189-8200, Vol. 79, No. 13
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.13.8189-8200.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sridhar, S., Reyes-Sandoval, A., Draper, S. J., Moore, A. C., Gilbert, S. C., Gao, G. P., Wilson, J. M., Hill, A. V. S.
(2008). Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A. J. Virol.
82: 3822-3833
[Abstract]
[Full Text]
-
Pan, C.-H., Nair, N., Adams, R. J., Zink, M. C., Lee, E.-Y., Polack, F. P., Singh, M., O'Hagan, D. T., Griffin, D. E.
(2008). Dose-Dependent Protection against or Exacerbation of Disease by a Polylactide Glycolide Microparticle-Adsorbed, Alphavirus-Based Measles Virus DNA Vaccine in Rhesus Macaques. CVI
15: 697-706
[Abstract]
[Full Text]
-
Koopman, G., Mortier, D., Hofman, S., Mathy, N., Koutsoukos, M., Ertl, P., Overend, P., van Wely, C., Thomsen, L. L., Wahren, B., Voss, G., Heeney, J. L.
(2008). Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian human immunodeficiency virus viraemia with protein/DNA combination. J. Gen. Virol.
89: 540-5533
[Abstract]
[Full Text]
-
Wang, X., Uto, T., Akagi, T., Akashi, M., Baba, M.
(2007). Induction of Potent CD8+ T-Cell Responses by Novel Biodegradable Nanoparticles Carrying Human Immunodeficiency Virus Type 1 gp120. J. Virol.
81: 10009-10016
[Abstract]
[Full Text]
-
Capone, S., Zampaglione, I., Vitelli, A., Pezzanera, M., Kierstead, L., Burns, J., Ruggeri, L., Arcuri, M., Cappelletti, M., Meola, A., Ercole, B. B., Tafi, R., Santini, C., Luzzago, A., Fu, T.-M., Colloca, S., Ciliberto, G., Cortese, R., Nicosia, A., Fattori, E., Folgori, A.
(2006). Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman Primates. J. Immunol.
177: 7462-7471
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.